Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications.

PubWeight™: 1.35‹?› | Rank: Top 10%

🔗 View Article (PMID 10585306)

Published in Am J Kidney Dis on December 01, 1999

Authors

S Bianchi1, R Bigazzi, V M Campese

Author Affiliations

1: Unita Operativa di Nefrologia, Spedali Riuniti, Livorno, Italy.

Articles citing this

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia (2008) 1.70

Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol (2009) 1.28

Cumulative systolic BP and changes in urine albumin-to-creatinine ratios in nondiabetic participants of the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol (2014) 0.94

Usefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men>40 years of age (from the Rancho Bernardo Study). Am J Cardiol (2008) 0.91

Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat. Am J Physiol Renal Physiol (2009) 0.89

Influence of albuminuria and glomerular filtration rate on blood pressure response to antihypertensive drug therapy. Vasc Health Risk Manag (2007) 0.88

The growing epidemic of hypertension among children and adolescents: a challenging road ahead. Pediatr Cardiol (2012) 0.86

Retinal arteriolar caliber and urine albumin excretion: the Multi-Ethnic Study of Atherosclerosis. Nephrol Dial Transplant (2011) 0.85

Assessment of dyslipidemia in pre-dialysis patients in south-west Nigeria. Niger Med J (2014) 0.78

Prevalence and control of hypertension and albuminuria in South Korea: focus on obesity and abdominal obesity in the Korean National Health and Nutrition Examination Survey, 2011-2012. PLoS One (2014) 0.76

Relationship Between Dyslipidemia and Albuminuria in Hypertensive Adults: A Nationwide Population-Based Study. Medicine (Baltimore) (2016) 0.75

Should we screen for microalbuminuria in essential hypertension? Am J Kidney Dis (1999) 0.75

Moderately increased albuminuria unmasked hypertension. BMJ Case Rep (2014) 0.75

Microalbuminuria in untreated prehypertension and hypertension without diabetes. Int J Clin Exp Med (2014) 0.75

Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes. Integr Blood Press Control (2010) 0.75

Urinary glycosaminoglycans in the course of familial Mediterranean fever. Eur J Pediatr (2003) 0.75

Articles by these authors

Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int (2006) 2.31

Effect of dietary sodium intake on intracellular calcium in lymphocytes of salt-sensitive hypertensive patients. Am J Hypertens (1992) 1.45

Disparate prognosis of thrombotic microangiopathy in HIV-infected patients with and without AIDS. Am J Nephrol (1996) 1.44

Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens (1996) 1.38

Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension (1991) 1.23

Acute renal failure during intermittent rifampicin therapy. Nephron (1973) 1.19

Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens (1998) 1.19

Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int (1982) 1.15

A limited renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens (1998) 1.13

Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int (1981) 1.11

Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens (1994) 1.10

Bilateral renal cortical necrosis in two patients with Neisseria meningitidis sepsis. Am J Nephrol (1991) 1.10

Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int (1997) 1.07

Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension (1994) 1.07

Unilateral breast enlargement secondary to hemodialysis arteriovenous fistula and subclavian vein occlusion. Nephron (1993) 1.05

Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens (1995) 0.99

Effect of sodium intake on plasma catecholamines in normal subjects. J Clin Endocrinol Metab (1979) 0.96

Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: role of insulin. Am J Hypertens (1996) 0.91

Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF). J Clin Invest (1997) 0.90

Association between hyperlipidemia and microalbuminuria in essential hypertension. Kidney Int Suppl (1999) 0.89

Long-term effects of enalapril and nicardipine on urinary albumin excretion in patients with chronic renal insufficiency: a 1-year follow-up. Am J Nephrol (1991) 0.88

Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure. Am J Physiol Heart Circ Physiol (2000) 0.87

Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension. Hypertension (1996) 0.87

Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron (1992) 0.86

Social "status" and biological "status": a comparison of grave goods and skeletal indicators from Pontecagnano. Am J Phys Anthropol (2001) 0.84

Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension (1994) 0.83

Enhanced glucose tolerance in spontaneously hypertensive rats. Pancreatic beta-cell hyperfunction with normal insulin sensitivity. Diabetes (1992) 0.82

Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension. J Nephrol (1998) 0.81

Tuberculosis of the spine (Pott's disease) in patients with end-stage renal disease. Am J Nephrol (1994) 0.81

Hypertension without peripheral insulin resistance in spontaneously hypertensive rats. Am J Physiol (1992) 0.81

Silent ischemia is more prevalent among hypertensive patients with microalbuminuria and salt sensitivity. J Hum Hypertens (2003) 0.81

Altered norepinephrine turnover in the brain of rats with chronic renal failure. J Am Soc Nephrol (1994) 0.80

Effect of phosphate depletion on blood pressure and vascular reactivity to norepinephrine and angiotensin II in the rat. Am J Physiol (1985) 0.80

Microalbuminuria in patients with essential hypertension. Effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker. Am J Hypertens (1991) 0.80

Altered norepinephrine turnover in the brown fat of rats with chronic renal failure. J Am Soc Nephrol (1994) 0.80

Pressor reactivity to norepinephrine and angiotensin in salt-sensitive hypertensive patients. Hypertension (1993) 0.79

Renal hemodynamics and pharmacokinetics of bevantolol in patients with impaired renal function. Am J Cardiol (1986) 0.79

Neurogenic factors in low renin essential hypertension. Am J Med (1980) 0.79

Autonomic nervous system dysfunction and impotence in uremia. Am J Nephrol (1982) 0.79

Calcium, parathyroid hormone, and sympathoadrenal system. Am J Nephrol (1986) 0.79

Intestinal absorption of calcium and calcium metabolism in patients with essential hypertension and normal renal function. Am J Hypertens (1991) 0.79

Autonomic nervous system dysfunction in patients with acute renal failure. Am J Nephrol (1982) 0.79

Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of clonidine in essential hypertension. Kidney Int (1980) 0.79

Effects of hypercalcemia and parathyroid hormone on blood pressure in normal and renal-failure rats. Am J Physiol (1986) 0.79

A 19-year-old female with fever, acroparesthesia, and progressive deterioration of renal function. Am J Nephrol (1996) 0.79

The role of hypertension in the progression of renal diseases. Am J Kidney Dis (1991) 0.78

Serum calcium, parathyroid hormone, and blood pressure. Am J Nephrol (1986) 0.78

Minoxidil: a review of its pharmacological properties and therapeutic use. Drugs (1981) 0.78

Plasma catecholamines and autonomic nervous system function in patients with early renal insufficiency and hypertension: effect of clonidine. Nephron (1984) 0.77

Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs. Am J Med (1992) 0.77

Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension? Curr Opin Nephrol Hypertens (2000) 0.77

Insulin resistance in microalbuminuric hypertension. Sites and mechanisms. Hypertension (1995) 0.77

Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure. J Am Coll Cardiol (1984) 0.77

Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study. Am J Kidney Dis (1994) 0.77

Microalbuminuria in essential hypertension. J Nephrol (1997) 0.77

Treatment of severe hypertension with minoxidil: advantages and limitations. J Clin Pharmacol (1979) 0.77

Pregnancy in patients on chronic ambulatory peritoneal dialysis. Am J Kidney Dis (1992) 0.77

Effects of acute and chronic treatment with clonidine. Chest (1983) 0.76

Pharmacokinetics of atenolol in patients treated with chronic hemodialysis or peritoneal dialysis. J Clin Pharmacol (1985) 0.76

Management of essential hypertension. Whom, when and how to treat. Contrib Nephrol (1987) 0.75

Hemodynamic alterations and urinary albumin excretion in patients with essential hypertension. Am J Kidney Dis (1993) 0.75

[Influence of bromazepam and of diazepam on the acute toxicity and ECG changes caused by nicotine in guinea pigs]. Boll Soc Ital Biol Sper (1974) 0.75

Central and renal hemodynamic effects and hormonal response to diltiazem in severe congestive heart failure. Am J Cardiol (1987) 0.75

Effects of enalapril on urinary protein excretion of essential and renal parenchymal hypertensive patients. Comparison between colorimetric and radioimmunological methods. J Nucl Med Allied Sci (1988) 0.75

[Effect of bradykinin on Ranvier's nodes of isolated nerve fibers in the frog]. Boll Soc Ital Biol Sper (1971) 0.75

Quiz of month: question 2. Am J Nephrol (1983) 0.75

[Medical treatment of malignant hypertension. Physiopathological basis and results of treatment with sympatholytic drugs, heparin and dipyridamole]. Minerva Nefrol (1975) 0.75

[Physio-pharmacology of coronary insufficiency. II]. Clin Ter (1974) 0.75

Hypertension, hyperlipidemia and microalbuminuria. Contrib Nephrol (1997) 0.75

[Study of adrenergic receptors of the lower third of the human esophagus and cardia]. Boll Soc Ital Biol Sper (1971) 0.75

Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases. Nephron (1995) 0.75

[Pharmacological action of DMPP on the human cardia]. Boll Soc Ital Biol Sper (1971) 0.75

[Choleretic action of furosemide and of theophylline in the rat]. Boll Soc Ital Biol Sper (1970) 0.75

[Importance of myogenic tonus for demonstration of the beta-receptors in isolated arterial preparation]. Boll Soc Ital Biol Sper (1968) 0.75

[Physio-pharmacology of coronary insufficiency. I]. Clin Ter (1974) 0.75

Prognosis in acute renal failure accompanied by jaundice. Nephron (1981) 0.75

[Studies of the vasorelaxing mechanism of nicotine made by an analysis of the functional groups of the substance]. Boll Soc Ital Biol Sper (1968) 0.75

Effect of hypercalcemia on renal sympathetic nervous system activity. Am J Nephrol (1992) 0.75

[Potentiation with cocaine of substances with tono-stimulating action on isolated arteries]. Boll Soc Ital Biol Sper (1969) 0.75

The kidney in hypertension. Introduction. Am J Nephrol (1983) 0.75

Biofiltration, a new method of short hemodiafiltration: preliminary report. Int J Artif Organs (1986) 0.75

Hemodiafiltration (HD-HF): one year follow-up of nine hours weekly. Int J Artif Organs (1984) 0.75

Sympatho-adrenal system and the kidney in hypertension. Am J Nephrol (1983) 0.75

[Choleretic action of ethacrynic acid in the rat]. Boll Soc Ital Biol Sper (1971) 0.75

Relationship between plasma catecholamines, plasma renin activity, aldosterone, and arterial pressure during postural stress in normal subjects. J Lab Clin Med (1980) 0.75

[Influence of bromazepam on the subacute toxicity and ECG changes caused by nicotine in guinea pigs]. Boll Soc Ital Biol Sper (1974) 0.75

[Ictero-uremigenic cholangitis]. Minerva Nefrol (1975) 0.75

Contrast-induced acute renal failure. Adv Exp Med Biol (1987) 0.75

[Effects of dipyridamole on the isolated rat uterus]. Boll Soc Ital Biol Sper (1974) 0.75